icon-    folder.gif   Conference Reports for NATAP  
 
  The 21st Conference of the Asian Pacific Association for the Study of the Liver
APASL Feb 17-20, 2011
Bangkok, Thailand
Back grey_arrow_rt.gif
 
 
 
Phase 2 Study of Pegylated Interferon Lambda for HCV: Safety, Viral Response, and Impact of Host Genotype Through Week 12
 
 
  Reported by Jules Levin
21st APASL Conference, Bangkok, Thailand, February 17-20, 2011
 
Rodriguez-Torres M,1 Lawitz E,2 Ghalib RH,3 Sussman NL,4 Anderson F,5 Everson GT,6 Jacobson IM,7 Lopez-Talavera JC,8 Horga M-A,8 Hillson JL,9 Gray TE,9 Fontana DJ,9 Ramos EL,9 Muir AJ10 1Fundacion de Investigacion de Diego, Santurce, Puerto Rico, USA; 2Alamo Medical Research, San Antonio, TX, USA; 3North Texas Research Institute, Dallas, TX, USA; 4Baylor College of Medicine, Houston, TX, USA; 5Liver and Intestinal Research Centre, Vancouver, BC, Canada; 6University of Colorado Hospital, Aurora, CO, USA; 7Weill Cornell Medical College, New York, NY, USA; 8Bristol-Myers Squibb, Wallingford, CT, USA; 9ZymoGenetics, Inc., Seattle, WA, USA; 10Duke University Medical Center, Durham, NC, USA

apasl1.gif

apasl2.gif

apasl3.gif

apasl4.gif

apasl5.gif

apasl6.gif

apasl7.gif

apasl8.gif

apasl9.gif

apasl10.gif

apasl11.gif

apasl12.gif

apasl13.gif

apasl14.gif